Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies

被引：26

作者：

Maccallini, Cristina ^{[1
]}

Montagnani, Monica ^{[2
]}

Paciotti, Roberto ^{[1
]}

Ammazzalorso, Alessandra ^{[1
]}

De Filippis, Barbara ^{[1
]}

Di Matteo, Mauro ^{[1
]}

Di Silvestre, Sara ^{[3
]}

Fantacuzzi, Marialuigia ^{[1
]}

Giampietro, Letizia ^{[1
]}

Potenza, Maria A. ^{[2
]}

Re, Nazzareno ^{[1
]}

Pandolfi, Assunta ^{[3
]}

Amoroso, Rosa ^{[1
]}

机构：

[1] Univ G dAnnunzio, Dept Pharm, I-66100 Chieti, Italy

[2] Univ Bari Aldo Moro, Sch Med, Dept Biomed Sci & Human Oncol, I-70121 Bari, Italy

[3] Univ G DAnnunzio, Aging Res Ctr, G dAnnunzio Univ Fdn, Dept Med Oral & Biotecnol Sci, I-66100 Chieti, Italy

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2015年 / 6卷 / 06期

关键词：

Acetamidine; inhibitor; molecular docking; nitric oxide synthases; synthesis; selective; DERIVATIVES; PEROXYNITRITE; TARGET;

D O I：

10.1021/acsmedchemlett.5b00149

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

N-[(3-Aminomethyl)benzyl]acetamidine derivatives were synthesized and in vitro evaluated as inhibitors of the inducible isoform of nitric oxide synthase (iNOS). Because of the high potency of action and the excellent selectivity over the endothelial nitric oxide synthase (eNOS), compound 10 was ex vivo evaluated on isolated and perfused resistance arteries. The results confirm that compound 10 selectively inhibits the iNOS, without affecting the endothelial isoform. The outcome of the docking studies showed that the hydrophobic interaction is the driving force of the binding process, especially for iNOS, where the binding pocket is characterized by a significant lipophilic region.

引用

页码：635 / 640

页数：6

共 50 条

[21] N,N′-Disubstituted thiourea and urea derivatives: design, synthesis, docking studies and biological evaluation against nitric oxide synthase
Chayah, Mariem
Encarnacion Camacho, M.
Dora Carrion, M.
Gallo, Miguel A.
Romero, Miguel
Duarte, Juan
MEDCHEMCOMM, 2016, 7 (04) : 667 - 678
[22] Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies
Karuppasamy, Muthukumar
Mahapatra, Manojkumar
Yabanoglu, Samiye
Ucar, Gulberk
Sinha, Barij Nayan
Basu, Arijit
Mishra, Nibha
Sharon, Ashoke
Kulandaivelu, Umasankar
Jayaprakash, Venkatesan
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (05) : 1875 - 1881
[23] Progress in the development of selective nitric oxide synthase (NOS) inhibitors
Salerno, L
Sorrenti, V
Di Giacomo, C
Romeo, G
Siracusa, MA
CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (03) : 177 - 200
[24] Discovery of selective inhibitors of neuronal nitric oxide synthase for neuroprotection
Reif, DW
CNS DRUG REVIEWS, 2000, 6 : 39 - 39
[25] Novel strategies in the development of selective nitric oxide synthase inhibitors
Mayer, B
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) : R1 - R1
[26] Discovery of potent and selective inhibitors of neuronal nitric oxide synthase
Ji, Haitao
Jing, Qing
Xue, Fengtian
Li, Huiying
Martasek, Pavel
Roman, Linda J.
Poulos, Thomas L.
Silverman, Richard B.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
[27] Homopiperidine amidines as selective inhibitors of inducible nitric oxide synthase
Hansen, DW
Peterson, KB
Trivedi, M
Webber, RK
Tjoeng, FS
Moore, WM
Jerome, GM
Currie, MG
Pitzele, BS
BIOLOGY OF NITRIC OXIDE, PT 5, 1996, 10 : 224 - 224
[28] Hydroxyethylene isosteres of selective neuronal nitric oxide synthase inhibitors
Erdal, Erik P.
Martasek, Pavel
Roman, Linda J.
Silverman, Richard B.
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (18) : 6096 - 6108
[29] Design of isoform-selective inhibitors of nitric oxide synthase
Babu, BR
Griffith, OW
CURRENT OPINION IN CHEMICAL BIOLOGY, 1998, 2 (04) : 491 - 500
[30] Nitric oxide synthase inhibitors
不详
EXPERT OPINION ON THERAPEUTIC PATENTS, 1997, 7 (10) : 1207 - 1210

← 1 2 3 4 5 →